Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
T Grewal, MKL Nguyen, C Buechler - Life Science Alliance, 2024 - life-science-alliance.org
The rapid development of vaccines to combat severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections has been critical to reduce the severity of COVID-19 …
coronavirus 2 (SARS-CoV-2) infections has been critical to reduce the severity of COVID-19 …
How likes and retweets impacted our patients during the COVID-19 pandemic
LG Ramirez, PG Wickner, NB Cline, N Rehman… - The Journal of Allergy …, 2023 - Elsevier
The growing dependence on social media for health-related information boomed during the
COVID-19 pandemic, posing unprecedented challenges in navigating the vast amounts of …
COVID-19 pandemic, posing unprecedented challenges in navigating the vast amounts of …
Considering ivermectin for treatment of schistosomiasis
J Golenser, I Birman, D Gold - Parasitology Research, 2024 - Springer
Because of recent reports of praziquantel resistance in schistosome infections, there have
been suggestions to employ ivermectin as a possible alternative, especially as its chemical …
been suggestions to employ ivermectin as a possible alternative, especially as its chemical …
[PDF][PDF] Negative Evidence: Repurposed Drugs for COVID-19: the Partisan Bone of Contention. Part I
JM Orient - Journal of American Physicians and Surgeons, 2024 - jpands.org
Partisan conflict over the efficacy of repurposed drugs emerged as one of most divisive
elements of the highly politicized response to the COVID-19 pandemic. This dispute …
elements of the highly politicized response to the COVID-19 pandemic. This dispute …
It's time for a booster: here's your 19th dose of Future Virology!
E Porter - Future Virology, 2024 - Taylor & Francis
As is tradition, this issue will begin with some of the content highlights from last year. First,
though, I'd like to take the opportunity to thank all our readers, authors and reviewers on …
though, I'd like to take the opportunity to thank all our readers, authors and reviewers on …